AtheroGenics to Report Fourth Quarter and Year-End 2007 Financial Results on February 14, 2008
           

ATLANTA, GA--(Marketwire - February 1, 2008) -  AtheroGenics, Inc. (NASDAQ: AGIX), a
pharmaceutical company focused on the treatment of chronic inflammatory
diseases, today announced that it will release its fourth quarter and
year-end 2007 financial results on Thursday, February 14, 2008 before the
U.S. financial markets open.

Conference Call and Webcast Information

Company officials will discuss fourth quarter and year-end results via
conference call and webcast on Thursday, February 14, 2008, at 9:00 a.m.
EST.  Participants may access the live conference call by dialing
877-407-8031 (domestic) or 201-689-8031 (international).  To access the
webcast, please visit the AtheroGenics Investor Relations website at
www.atherogenics.com.  A replay of the conference call will be accessible
approximately one hour after the conclusion of the call by dialing
877-660-6853 (domesti
           

http://www.marketwire.com/mw/release.do?id=816640&sourceType=3